E-LIB Suche - Ergebnisse für: Fiets, W. Edward

1

Assessing the clinical benefit of systemic anti-cancer trea..:

Leeneman, Brenda ; Xander, Nicolas S.H. ; Fiets, W. Edward...
European Journal of Cancer. 202 (2024) - p. 114002 , 2024

Link: https://doi.org/10.1016/..

2

Cost-effectiveness and budget impact of pembrolizumab+axiti..:

Xander, Nicolas S. H. ; Fiets, W. Edward ; Uyl-de Groot, Carin A.
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Methotrexate plus or minus cetuximab as first‐line treatmen..:

Ham, Janneke C. ; van Meerten, Esther ; Fiets, W. Edward...
Head & Neck. 42 (2020) 5 - p. 828-838 , 2020

Link: https://doi.org/10.1002/..

4

Lactate dehydrogenase as a selection criterion for ipilimum..:

Kelderman, Sander ; Heemskerk, Bianca ; van Tinteren, Harm...
Cancer Immunology, Immunotherapy. , 2014

Link: https://doi.org/10.1007/..

5

Using non-randomized trials to assess the clinical benefit ..:

Xander, N.S.H. ; Leeneman, B. ; Dingemans, A.-M.C....
European Journal of Cancer. 209 (2024) - p. 114262 , 2024

Link: https://doi.org/10.1016/..

6

CO131 Using Non-Randomized Trials to Assess the Clinical Be..:

Xander, N. ; Leeneman, B. ; Dingemans, A.M.C....
Value in Health. 26 (2023) 12 - p. S37-S38 , 2023

Link: https://doi.org/10.1016/..

7

Prophylactic antibiotics reduce hospitalisations and cost i..:

Ham, Janneke C. ; Driessen, Chantal M. ; Hendriks, Mathijs P....
European Journal of Cancer. 113 (2019) - p. 32-40 , 2019

Link: https://doi.org/10.1016/..

8

Androgen deprivation therapy for androgen receptor‐positive..:

Boon, Eline ; van Boxtel, Wim ; Buter, Jan...
Head & Neck. 40 (2017) 3 - p. 605-613 , 2017

Link: https://doi.org/10.1002/..

9

The in- or exclusion of non-breast cancer related death and..:

Nout, R. A. ; Fiets, W. E. ; Struikmans, H....
Breast Cancer Research and Treatment. 109 (2007) 3 - p. 567-572 , 2007

Link: https://doi.org/10.1007/..

10

2085 POSTER Stage migration in breast cancer: a trend towar..:

Gobardhan, P. ; Bakker, O.J. ; Fiets, W.E...
European Journal of Cancer Supplements. 5 (2007) 4 - p. 208-209 , 2007

Link: https://doi.org/10.1016/..

11

Prognostic value of mitotic counts in axillary node negativ..:

Fiets, W.E. ; Bellot, F.E. ; Struikmans, H...
European Journal of Surgical Oncology (EJSO). 31 (2005) 2 - p. 128-133 , 2005

Link: https://doi.org/10.1016/..

12

Prognostic factors in breast cancer are highly influenced b..:

Fiets, W.E ; Nortier, J.W.R ; Blankenstein, M.A.
European Journal of Cancer Supplements. 2 (2004) 3 - p. 174 , 2004

Link: https://doi.org/10.1016/..

13

The Prognostic Value of Hormone Receptor Detection by Enzym..:

Fiets, W.E. ; Blankenstein, M.A. ; Struikmans, H...
The International Journal of Biological Markers. 17 (2002) 1 - p. 24-32 , 2002

Link: https://doi.org/10.1177/..

14

Pooled Analysis of Prognostic Impact of Urokinase-Type Plas..:

Look, M. P. ; van Putten, W. L. J. ; Duffy, M. J....
JNCI Journal of the National Cancer Institute. 94 (2002) 2 - p. 116-128 , 2002

Link: https://doi.org/10.1093/..

15

Prognosticators in axillary node negative breast cancer:

Fiets, W.E. ; Blankenstein, M.A. ; Nortier, J.W.R....
European Journal of Cancer. 34 (1998) - p. S106 , 1998

Link: https://doi.org/10.1016/..